Feb 26, 2026 07:00AM

Feb 26, 2026 07:00AM

Feb 26, 2026 07:00AM

Feb 25, 2026 07:00AM

Feb 4, 2026 07:30AM

Feb 4, 2026 07:30AM

Jul 30, 2025 07:00AM Ionis reports second quarter 2025 financial results and highlights progress on key programs

Jul 21, 2025 07:00AM

Jul 21, 2025 07:00AM

Apr 30, 2025 07:00AM

Apr 7, 2025 06:34AM

Feb 20, 2025 07:03AM

Feb 20, 2025 07:00AM

Feb 20, 2025 05:50AM Ionis Pharmaceuticals (IONS) PT Lowered to $60 at Raymond James

Feb 19, 2025 02:52PM

Feb 19, 2025 07:00AM

Dec 20, 2024 07:18AM

Nov 6, 2024 07:00AM

Nov 4, 2024 09:45AM

Nov 4, 2024 09:44AM

Sep 26, 2024 06:23AM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)

Aug 1, 2024 07:00AM

Jun 25, 2024 06:55AM

Jun 25, 2024 06:55AM

Mar 13, 2024 03:02PM

Oct 4, 2023 07:00AM

Sep 28, 2023 12:02PM

Aug 9, 2023 07:00AM Ionis reports second quarter 2023 financial results

Jul 31, 2023 07:05AM

Jul 28, 2023 07:05AM

Jul 28, 2023 07:05AM

Jul 10, 2023 07:05AM

Jul 10, 2023 07:05AM

Apr 24, 2023 07:01AM

Apr 24, 2023 07:00AM Eplontersen halted ATTRv-PN disease progression and improved neuropathy impairment and quality of life in Phase 3 study through 66 weeks

Mar 27, 2023 05:49AM

Mar 27, 2023 02:00AM

Mar 23, 2023 05:31AM

Mar 22, 2023 11:01PM

Mar 7, 2023 07:06AM

Mar 7, 2023 07:05AM

Feb 22, 2023 07:01AM Ionis reports fourth quarter and full year 2022 financial results

Jan 26, 2023 09:30AM

Dec 5, 2022 07:34AM

Dec 5, 2022 07:30AM

Nov 9, 2022 07:00AM

Aug 9, 2022 07:00AM

Jul 26, 2022 07:31AM

Jul 26, 2022 07:30AM Ionis announces that FDA accepts New Drug Application and grants Priority Review of tofersen for a rare, genetic form of ALS

Jan 30, 2020 11:13AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All